TrialArteriosclerosis, thrombosis, and vascular biology2022

Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study.

Eric Bruckert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.